by Nakita | Jun 11, 2026 | Latest News, Research Opportunities
In this article, we use “lupus” instead of “SLE” (systemic lupus erythematosus). In England and Wales, doctors can use a medicine called obinutuzumab to treat kidney disease caused by lupus. You might know this as lupus nephritis. Research has shown that obinutuzumab...
by Nakita | May 22, 2026 | Latest News
People living with immune-mediated inflammatory diseases (IMIDs), including lupus, in Scotland face persistent challenges in accessing timely diagnosis, equitable care, and the support needed to manage lifelong, complex conditions. The Scottish Report, led by the...
by Nakita | Feb 28, 2026 | Latest News
NICE publishes Quality Standard for rare disease NICE has published a Quality Standard for Rare Disease which sets out what high-quality sustainable care, treatment, and management should look like for rare diseases. We hope that this will help improve services, care,...
by Nakita | Jan 22, 2026 | Latest News
NICE approves obinutuzumab to treat lupus nephritis in England and Wales NICE have recommended that a new treatment, obinutuzumab, can be used in combination with mycophenolate mofetil (MMF) to treat some patients with lupus nephritis in the NHS in England and Wales. ...
by Nakita | Nov 21, 2025 | Latest News
Stay Protected This Winter: Flu, COVID-19, and RSV Vaccines During the colder months, viruses like flu, COVID-19, and respiratory syncytial virus (RSV) circulate more widely. For people with lupus, especially those taking immunosuppressive medicines, these infections...
by Nakita | Oct 14, 2025 | Latest News
Introducing the Lupus UK Research Network Explores the Lupus UK Research Network, the benefits of getting involved and answers common questions Published: November 2025. Reading time:10 mins Research into lupus has made great progress, helping us understand more than...
